Skip to main content
SpringerLink
Log in

Diseases of the Liver: Liver Masses (Hemangioma, Focal Nodular Hyperplasia, Hepatic Adenoma)

  • Chapter
  • First Online:
Gastrointestinal and Liver Disorders in Women’s Health

  • 306 Accesses

Abstract

Increased availability and use of sensitive diagnostic abdominal imaging have led to the detection of benign focal liver lesions in many patients. These are a heterogenous group of nodular lesions, arising from different cell lines, including mesenchymal cells, hepatocytes, or cholangiocytes, often found in the background of an otherwise normal-appearing liver. This chapter will focus on three common benign focal liver lesions encountered in clinical practice, including hepatic hemangioma, focal nodular hyperplasia (FNH), and hepatic adenoma (HA), which offer diverse diagnostic and management challenges for the provider. The prevalence of these benign liver lesions is significantly higher in women.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ishak KG, Rabin L. Benign tumors of the liver. Med Clin North Am. 1975;59(4):995–1013.

    Article  CAS  Google Scholar 

  2. Gandolfi L, Leo P, Solmi L, et al. Natural history of hepatic haemangiomas: clinical and ultrasound study. Gut. 1991;32:677.

    Article  CAS  Google Scholar 

  3. Adam YG, Huvos AG, Fortner JG. Giant hemangiomas of the liver. Ann Surg. 1970;172(2):239–45.

    Article  CAS  Google Scholar 

  4. Hall GW. Kasabach-Merritt syndrome: pathogenesis and management. Br J Haematol. 2001;112(4):851–62.

    Article  CAS  Google Scholar 

  5. Yoon SS, Charny CK, Fong Y, et al. Diagnosis, management, and outcomes of 115 patients with hepatic hemangioma. J Am Coll Surg. 2003;197(3):392–402.

    Article  Google Scholar 

  6. Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology. 1990;11:787–97.

    Article  CAS  Google Scholar 

  7. Karhunen PJ. Benign hepatic tumours and tumour like conditions in men. J Clin Pathol. 1986;39:183–8.

    Article  CAS  Google Scholar 

  8. Vilgrain V, Uzan F, Brancatelli G, et al. Prevalence of hepatic hemangioma in patients with focal nodular hyperplasia: MR imaging analysis. Radiology. 2003;229:75–9.

    Article  Google Scholar 

  9. Gaffey MJ, Lezzoni JC, Weiss LM. Clonal analysis of focal nodular hyperplasia of the liver. Am J Pathol. 1996;148:1089–96.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Paradis V, Laurent A, Flejou JF, et al. Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X-chromosome inactivation. Hepatology. 1997;26:891–5.

    Article  CAS  Google Scholar 

  11. Baum JK, Bookstein JJ, Holtz F, Klein EW. Possible association between benign hepatomas and oral contraceptives. Lancet. 1973;2:926.

    Article  CAS  Google Scholar 

  12. Edmondson HA, Henderson B, Benton B. Liver-cell adenomas associated with the use of oral contraceptives. N Engl J Med. 1976;294:470.

    Article  CAS  Google Scholar 

  13. Rooks JB, Ory HW, Ishak KG, et al. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA. 1979;242:644.

    Article  CAS  Google Scholar 

  14. Nime F, Pickren JW, Vana J, et al. The histology of liver tumors in oral contraceptive users observed during a national survey by the American College of Surgeons Commission on Cancer. Cancer. 1979;22:1481.

    Article  Google Scholar 

  15. Rosenberg L. The risk of liver neoplasia in relation to combined oral contraceptive use. Contraception. 1991;43:643.

    Article  CAS  Google Scholar 

  16. Soe KL, Soe M, Gluud C. Liver pathology associated with the use of anabolic-androgenic steroids. Liver. 1992;12:73.

    Article  CAS  Google Scholar 

  17. Kent DR, Nissen ED, Nissen SE, Ziehm DJ. Effect of pregnancy on liver tumor associated with oral contraceptives. Obstet Gynecol. 1978;51:148.

    CAS  PubMed  Google Scholar 

  18. Nault JC, Couchy G, Balabaud C, et al. Molecular classification of hepatocellular adenoma associates with risk factors, bleeding and malignant transformation. Gastroenterology. 2017;152:880–94.

    Article  CAS  Google Scholar 

  19. Van der Borght S, Libbrecht L, Katoonizadeh A, et al. Nuclear beta-catenin staining and absence of steatosis are indicators of hepatocellular adenomas with an increased risk for malignancy. Histopathology. 2007;51:855–6.

    Article  Google Scholar 

  20. Farges O, Ferreira N, Dokmak S, et al. Changing trends in malignant transformation of hepatocellular adenoma. Gut. 2011;60:85–9.

    Article  Google Scholar 

  21. Stoot JH, Coelen RJ, De Jong MC, et al. Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford). 2010;12:509–22.

    Article  Google Scholar 

  22. Klompenhouwer AJ, Broker MEE, Thomeer MGJ, et al. Retrospective study on timing of resection of hepatocellular adenoma. Br J Surg. 2017;104:1695.

    Article  CAS  Google Scholar 

  23. McInnes MD, Hibbert RM, Inacio JR, et al. Focal nodular hyperplasia and hepatocellular adenoma: accuracy of gadoxetic acid-enhanced MR imaging—a systemic review. Radiology. 2015;277:927.

    Article  Google Scholar 

Download references

Acknowledgments

I would like to extend my sincerest thanks to Dr. Timothy Ziemlewicz and Dr. Rashmi Agni for their generous assistance in providing pertinent radiology and pathology figures for use in this chapter.

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Department of Medicine, University of Wisconsin School of Medicine and Public Health and Wm S Middleton VAMC, Madison, WI, USA

    Parul D. Agarwal & Adnan Said

Authors
  1. Parul D. Agarwal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adnan Said
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adnan Said .

Editor information

Editors and Affiliations

  1. Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI, USA

    Poonam Beniwal-Patel

  2. Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI, USA

    Reza Shaker

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Agarwal, P.D., Said, A. (2019). Diseases of the Liver: Liver Masses (Hemangioma, Focal Nodular Hyperplasia, Hepatic Adenoma). In: Beniwal-Patel, P., Shaker, R. (eds) Gastrointestinal and Liver Disorders in Women’s Health . Springer, Cham. https://doi.org/10.1007/978-3-030-25626-5_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-25626-5_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-25625-8

  • Online ISBN: 978-3-030-25626-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation